Post-approval studies (Phase 4)Study completedNCT00334035What this trial is testingAntipsychotic Therapy and First EpisodeWho this might be right forSchizophrenia The University of Hong Kong 169
Testing effectiveness (Phase 2)Ended earlyNCT00686699What this trial is testingStudy of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)Who this might be right forAkathisia, Drug-InducedDyskinesia, Drug-InducedParkinsonian Disorders Merck Sharp & Dohme LLC 11
Large-scale testing (Phase 3)Study completedNCT01143077What this trial is testingA Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic AgentsWho this might be right forSchizophreniaSchizoaffective Disorder Sumitomo Pharma America, Inc. 244
Post-approval studies (Phase 4)Ended earlyNCT00508157What this trial is testingAssess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic SyndromeWho this might be right forMetabolic SyndromeSchizophrenia Bristol-Myers Squibb 125
Large-scale testing (Phase 3)UnknownNCT01280305What this trial is testingRaloxifene in Treatment of Schizophrenia and Schizoaffective DisorderWho this might be right forSchizophreniaSchizoaffective Disorder Sheba Medical Center 200
Large-scale testing (Phase 3)Study completedNCT00649844What this trial is testingA Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic DrugsWho this might be right forSchizophrenia Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 147
Not applicableStudy completedNCT00222807What this trial is testingSchizophrenia, Antipsychotic Treatment and the Risk for Diabetes MellitusWho this might be right forSchizophreniaSchizoaffective DisorderDelusional Disorder University of Pittsburgh 200
Not applicableStudy completedNCT01222494What this trial is testingHealthy Bodies, Healthy KidsWho this might be right forChild Mental DisordersObesityMetabolic Syndrome Washington University School of Medicine 47
Not applicableUnknownNCT01831986What this trial is testingPregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective DisordersWho this might be right forSchizophreniaSchizoaffective Disorder Sha'ar Menashe Mental Health Center 60
Not applicableStudy completedNCT01234454What this trial is testingAtypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRIWho this might be right forSchizophrenia University of North Carolina, Chapel Hill 34
Post-approval studies (Phase 4)WithdrawnNCT01193166What this trial is testingTwelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric HospitalWho this might be right forSchizophrenia Ortho-McNeil Janssen Scientific Affairs, LLC
Large-scale testing (Phase 3)Study completedNCT00083668What this trial is testingTrial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With SchizophreniaWho this might be right forSchizophrenia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 619
Large-scale testing (Phase 3)Study completedNCT01421342What this trial is testingVA Augmentation and Switching Treatments for Improving Depression OutcomesWho this might be right forMajor Depressive Disorder VA Office of Research and Development 1,522
Not applicableUnknownNCT03434210What this trial is testingThe Effect of a Community-based LAT-treated Management Model on the Violence Risk of Patients With SchizophreniaWho this might be right forSchizophrenia Yi Li MD, PhD 110
Large-scale testing (Phase 3)Study completedNCT00167154What this trial is testingRisperidone and Suicidality in Major Depressive DisorderWho this might be right forDepression University of Alabama at Birmingham 30
Not applicableStudy completedNCT00696813What this trial is testingObservational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral AntipsychoticsWho this might be right forSchizophrenia Janssen-Cilag International NV 3,064
Not applicableStudy completedNCT01804582What this trial is testingThe Family VOICE StudyWho this might be right forAutismAggressionBipolar Disorder+1 more University of Maryland, Baltimore 350
Early research (Phase 1)Study completedNCT00791622What this trial is testingQT and QTc Intervals in Patients Administered Extended Release Paliperidone or QuetiapineWho this might be right forSchizophreniaSchizoaffective Disorder Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 110
Large-scale testing (Phase 3)Study completedNCT01994109What this trial is testingEfficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult SubjectsWho this might be right forSialorrhea Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC 187
Large-scale testing (Phase 3)Study completedNCT00518323What this trial is testingA Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent PatientsWho this might be right forSchizophrenia Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201